Insulin mouth rinse - EastGate Biotech
Alternative Names: Insugin; Liquid insulin mouth rinse - EastGate BiotechLatest Information Update: 28 Jul 2022
At a glance
- Originator EastGate Biotech
- Developer EastGate Biotech; Genome Pharmaceuticals
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease; Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for research development in Alzheimer's-disease in Pakistan (Buccal)
- 26 Jul 2022 No development reported - Phase-II for Type 1 diabetes mellitus (Adjunctive treatment) in Pakistan (Buccal)
- 26 Jul 2022 No development reported - Phase-II for Type 2 diabetes mellitus (Adjunctive treatment) in Pakistan (Buccal)